Weight Loss Options
Semaglutide (Ozempic Generic)
Tirzepatide (Mounjaro Generic)
$299 Month Supply
Semaglutide belongs to a class of medications known as glucagon-like peptide-1 receptor agonists, or GLP-1 RAs. It mimics the GLP-1 hormone, released in the gut in response to eating. One role of GLP-1 is to prompt the body to produce more insulin, which reduces blood sugar (glucose). For that reason, health care
$299 Month Supply
Semaglutide belongs to a class of medications known as glucagon-like peptide-1 receptor agonists, or GLP-1 RAs. It mimics the GLP-1 hormone, released in the gut in response to eating. One role of GLP-1 is to prompt the body to produce more insulin, which reduces blood sugar (glucose). For that reason, health care providers have used Semaglutide for more than 15 years to treat Type 2 diabetes. But GLP-1 in higher amounts also interacts with the parts of the brain that suppress your appetite and signal you to feel full. When used in conjunction with diet and exercise, it can cause significant weight loss and reduce your risk of cancer, diabetes and heart disease.
Tirzepatide (Mounjaro Generic)
Tirzepatide (Mounjaro Generic)
First Month ------ $399
*higher doses may increase price
Tirzepatide, a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) receptor agonist, is approved for the treatment of type 2 diabetes (T2D). Tirzepatide causes robust body weight loss mainly by reduction in energy intake and by increasing
First Month ------ $399
*higher doses may increase price
Tirzepatide, a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) receptor agonist, is approved for the treatment of type 2 diabetes (T2D). Tirzepatide causes robust body weight loss mainly by reduction in energy intake and by increasing energy expenditure in preclinical models and has demonstrated robust body weight reductions in people with T2D. We hypothesized that body weight loss with Tirzepatide is mainly driven by reduced energy intake.
Retatrutide (New Gen)
Retatrutide (New Gen)
The war against fat loss is over! The winner is Retatrutide. Schedule a consult today!
New Product
Price: $599 monthly
Retatrutide (LY3437943; Eli Lilly) is a single peptide conjugated to a fatty diacid moiety and has agonism toward the GIP, GLP-1, and GCG receptors. As compared with the endogenous receptor ligands, retatrutide i
The war against fat loss is over! The winner is Retatrutide. Schedule a consult today!
New Product
Price: $599 monthly
Retatrutide (LY3437943; Eli Lilly) is a single peptide conjugated to a fatty diacid moiety and has agonism toward the GIP, GLP-1, and GCG receptors. As compared with the endogenous receptor ligands, retatrutide is less potent at the human GCG and GLP-1 receptors (by a factor of 0.3 and 0.4, respectively) and is more potent and has been shown to acheive more than 17.5% weight reduction in adults. The drug is a peptide with amino acid sequuence.
